CCL19 has also been shown to be overexpressed in cervical cancer tissue and cell lines with siRNA-induced a reduction in CCL19 inhibiting cervical cancer cell proliferation and increased levels of apoptosis, suggesting that CCL19 via CCR7 activation is a driving force of cervical cancer progression [94]. The gene discussed is CCR7; the disease is cervical carcinoma.